COVID-19 vaccine effectiveness
If you want to see all comparisons, please click here
EpiVacCorona vs Placebo
You will find below the forest plots for this comparison with the general characteristics and risk of bias assessment for all RCTs identified.
Of note all trials may not be included in the synthesis.
|Trial||Type||Comparisons||Design||Participants||Sample size||Overall risk
|Intervention 1||Intervention 2|
EpiVac LLC ; State Scientific Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
Ryzhikov AB, Infektsiia Immun, 2021
|RCTPhase 2||Healthy adult SARS-CoV-2 infection-free volunteers in a single center in Russia.||N=86||